Regadenoson - CISMeF

Preferred Label : Regadenoson;

NCIt synonyms : Adenosine, 2-(4-((methylamino)carbonyl)-1H-pyrazol-1-yl)-;

NCIt definition : An adenosine derivative and selective A2A adenosine receptor agonist with coronary vasodilating activity. Upon administration, regadenoson selectively binds to and activates the A2A adenosine receptor, which induces coronary vasodilation. This leads to an increase in coronary blood flow and enhances myocardial perfusion. Compared to adenosine, regadenoson has a longer half-life and shows higher selectivity towards the A2A adenosine receptor. This agent is a very weak agonist for the A1 adenosine receptor and has negligible affinity for the A2B and A3 adenosine receptors.;

UNII : 2XLN4Y044H;

InChIKey : CDQVVPUXSPZONN-WPPLYIOHSA-N;

CAS number : 313348-27-5; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 313348-27-5 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ;

Molecule name : CVT-3146;

Chemical formula : C15H18N8O5.H2O;

Details

Origin ID

C74420;

UMLS CUI

C1698215;

Automatic exact mappings (from CISMeF team)
- Regadenoson [ICD-11 Extension code]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Product containing regadenoson (medicinal product) [SNOMED CT concept]
- Regadenoson (substance) [SNOMED CT concept]
- regadenoson [ATC Code]
- regadenoson [MeSH Supplementary Concept]
- regadenoson [MeSH concept]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
- NCI Drug Dictionary Terminology [NCIt concept]
- NCIt COVID-19 Agent Terminology [NCIt concept]
- NCIt COVID-19 Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients